Research GAN Update
For our community members affected by GAN We wanted to share news we’ve received with our community members affected by giant axonal neuropathy (GAN). Taysha has made the difficult decision to discontinue the development of the investigational gene therapy candidate, TSHA-120, for the treatment of GAN.